NuCana (NCNA) Cash & Equivalents (2015 - 2025)

NuCana (NCNA) reported Cash & Equivalents of $32.3 million for Q4 2025, up 272.39% on a YoY basis from $8.7 million in Q4 2024, and down 5.32% sequentially from $34.1 million in Q3 2025.

NuCana (NCNA) Cash & Equivalents (2015 - 2025) Analysis & Trends

NuCana (NCNA) has 11 years of Cash & Equivalents data on file, last reported at $32.3 million in Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents rose 272.39% year-over-year to $32.3 million; the trailing twelve-month figure through Dec 2025 stood at $32.3 million (up 272.39% YoY), and the FY2025 full-year result was $32.0 million, up 270.64% from the prior year.
  • Cash & Equivalents retreated to $32.3 million in Q4 2025, from $34.1 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $108.4 million in Q1 2021 to a low of $5.0 million in Q1 2025.
  • A 5-year average of $43.9 million and a median of $33.2 million in 2025 frame the typical range for Cash & Equivalents.
  • Peak annual rise in Cash & Equivalents reached 272.39% in 2025, while the deepest fall reached 69.5% in 2025.
  • Tracing NCNA's Cash & Equivalents over 5 years: stood at $81.2 million in 2021, then tumbled by 39.49% to $49.2 million in 2022, then plunged by 56.51% to $21.4 million in 2023, then plunged by 59.48% to $8.7 million in 2024, then surged by 272.39% to $32.3 million in 2025.
  • Business Quant data shows NCNA's Cash & Equivalents at $32.3 million in Q4 2025, $34.1 million in Q3 2025, and $11.3 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 82.45 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 61.40 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 4.79 Bn
4 NuCana 279.75 Bn 279.75 Bn - 32.26 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.49 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.96 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 3.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 440.94 Mn
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn 1.71 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 32.26 Mn
Sep 30, 2025 34.07 Mn
Jun 30, 2025 11.26 Mn
Mar 31, 2025 4.98 Mn
Dec 31, 2024 8.66 Mn
Sep 30, 2024 14.75 Mn
Jun 30, 2024 14.69 Mn
Mar 31, 2024 16.32 Mn
Dec 31, 2023 21.38 Mn
Sep 30, 2023 22.55 Mn
Jun 30, 2023 30.84 Mn
Mar 31, 2023 37.68 Mn
Dec 31, 2022 49.16 Mn
Sep 30, 2022 59.81 Mn
Jun 30, 2022 58.59 Mn
Mar 31, 2022 70.53 Mn
Dec 31, 2021 81.24 Mn
Sep 30, 2021 97.92 Mn
Jun 30, 2021 102.62 Mn
Mar 31, 2021 108.42 Mn